igeahub.com
Teva Announces FDA Approval of ProAir RespiClick® (albuterol sulfate) Inhalation Powder for Patients with Pediatric Asthma - IgeaHub
Apr. 29, 2016 Teva Pharmaceutical Industries Ltd. has announced that the U.S. Food and Drug Administration (FDA) has approved ProAir